Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 6, Status: Authorised

Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.